Insight Innovation: Die mächtigen neuen Türsteher der KI-Wirtschaft
Unternehmen klagen über hohe KI-Kosten und setzen vermehrt sogenannte Router ein, um Geld zu sparen. Sie entscheiden, welches Modell wo eingesetzt wird. Es entsteht ein Milliardenmarkt.
Düsseldorf and San Francisco. Inside each cell lies 3.5 billion bits of data, while the entire body contains over 40 billion. Bayer is researching at a level beyond human perception and understanding. Artificial intelligence (AI) assists the pharmaceutical giant in drawing insights from this vast ocean of information to identify potential starting points for new medications, such as those targeting cancer or cardiovascular diseases.
The situation appears promising thus far. However, Bernd Lohmann, CTO of the group, faces a challenge: the cost of AI implementation. Individual employees already incur AI expenses of over 5,000 euros per month. "Luckily, not everyone is a super-user," Lohmann remarked at a Trade Newspaper conference on Datacenter Location Germany, speaking to the nearly 90,000 employees of the group.
AI proves useful and may decide the economic future of companies like Bayer. The next life-saving or curative medication could be found by AI. Yet, the costs must not spiral out of control. Lohmann tackles this economic issue with a technical solution: a model router.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
